Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
BRIDGEBIO PHARMA INC
CUSIP: 10806XAD4
Class: Convertible Debt
CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)
Note: Option positions (PUT/CALL) are excluded.
Q4 2025
Shares
5,000,000
Value ($000)
$5,631
Avg Close
—
Range
—
Q2 2023
Shares
1,500,000
Value ($000)
$926
Avg Close
—
Range
—
Period
Shares
Value ($000)
Average Close
Price Range
Q4 2025
5,000,000
$5,631
—
—
Q2 2023
1,500,000
$926
—
—